» Articles » PMID: 27363496

Prognostic Values of Four Notch Receptor MRNA Expression in Gastric Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jul 2
PMID 27363496
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Notch ligands and receptors are frequently deregulated in several human malignancies including gastric cancer. The activation of Notch signaling has been reported to contribute to gastric carcinogenesis and progression. However, the prognostic roles of individual Notch receptors in gastric cancer patients remain elusive. In the current study, we accessed the prognostic roles of four Notch receptors, Notch 1-4, in gastric cancer patients through "The Kaplan-Meier plotter" (KM plotter) database, in which updated gene expression data and survival information include a total of 876 gastric cancer patients. All four Notch receptors' high mRNA expression was found to be correlated to worsen overall survival (OS) for all gastric cancer patients followed for 20 years. We further accessed the prognostic roles of individual Notch receptors in different clinicopathological features using Lauren classification, pathological grades, clinical grades, HER2 status and different choices of treatments of gastric cancer patients. These results indicate that there are critical prognostic values of the four Notch receptors in gastric cancer. This information will be useful for better understanding of the heterogeneity and complexity in the molecular biology of gastric cancer and to develop tools to more accurately predict their prognosis.

Citing Articles

AKT1-Mediated NOTCH1 phosphorylation promotes gastric cancer progression via targeted regulation of IRS-1 transcription.

Zhou L, Yang Y, Qiao Q, Mi Y, Gan Y, Zheng Y J Cancer Res Clin Oncol. 2024; 151(1):15.

PMID: 39724412 PMC: 11671552. DOI: 10.1007/s00432-024-06039-z.


Notch1 signaling pathway promotes growth and metastasis of gastric cancer via modulating CDH5.

Zhou L, Yang Y, Ye Y, Qiao Q, Mi Y, Liu H Aging (Albany NY). 2024; 16(16):11893-11903.

PMID: 39172098 PMC: 11386911. DOI: 10.18632/aging.206061.


Vil-Cre specific Slfn3KO mice exhibit sex-specific differences in lung, stomach, cecum, kidney, and proximal colon differentiation markers and Slfn family members expression levels.

Vomhof-DeKrey E, Rajpathy O, Preszler E, Basson M Biochem Biophys Rep. 2023; 36:101552.

PMID: 38076659 PMC: 10709030. DOI: 10.1016/j.bbrep.2023.101552.


Investigation of the impact of Globo-H expression on the progression of gastric cancer.

Hsu H, Kuo T, Wei C, Huang J, Liu T, Hsing M Am J Cancer Res. 2023; 13(7):2969-2983.

PMID: 37560002 PMC: 10408484.


The potential of mRNA expression evaluation in predicting HER2 positivity in gastroesophageal cancer.

Oliveira I, Nicolau-Neto P, Fernandes P, Lavigne T, Neves P, Tobar J Braz J Med Biol Res. 2022; 55:e12428.

PMID: 36383805 PMC: 9668082. DOI: 10.1590/1414-431X2022e12428.


References
1.
Bauer L, Takacs A, Slotta-Huspenina J, Langer R, Becker K, Novotny A . Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study. Front Oncol. 2015; 5:94. PMC: 4406075. DOI: 10.3389/fonc.2015.00094. View

2.
Oba K, Paoletti X, Bang Y, Bleiberg H, Burzykowski T, Fuse N . Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer. 2013; 49(7):1565-77. DOI: 10.1016/j.ejca.2012.12.016. View

3.
Miele L . Notch signaling. Clin Cancer Res. 2006; 12(4):1074-9. DOI: 10.1158/1078-0432.CCR-05-2570. View

4.
Zhou C, Zhong Q, Rhodes L, Townley I, Bratton M, Zhang Q . Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Res. 2012; 14(2):R45. PMC: 3446379. DOI: 10.1186/bcr3144. View

5.
Adam Maciejczyk A . New prognostic factors in breast cancer. Adv Clin Exp Med. 2013; 22(1):5-15. View